MECP2 and Leigh syndrome: These novel MeCP2 targets as well as others in Figure S1 had not previously been linked with MeCP2, but have been linked with pathobiology associated with cancer (76–84) or genetic disorders such as Leigh syndrome (85) and Raine syndrome (86, 87).